Both in Pharmaceuticals
Artelo Biosciences vs Oragenics
Over the past year ARTL returned −97.4% and OGEN returned −64.2%; their daily moves had a correlation of 0.02.
ARTL −97.4% OGEN −64.2%Growth of $1, one year, split-adjusted
| Metric | ARTL | OGEN |
|---|---|---|
| Price | $4.07 | $0.4800 |
| Market cap | $2.2M | $2.2M |
| Today | −5.35% | +1.78% |
| 1 month | −92.4% | −8.4% |
| 6 months | −94.8% | −4.7% |
| Year to date | −87.6% | −38.7% |
| 1 year | −97.3% | −62.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.2M | $3.9M |
| Dividend yield | — | — |
| Volatility (60d) | 651.8% | 45.4% |
| Short % of float | 0.5% | 23.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).